Search
for
Sort by
Research 31–60 of 1000+
- Polycystic Ovary Syndrome
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Obesity and the Polycystic Ovary Syndrome
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Biochemical and Structural Characteristics, Gene Regulation, Physiological, Pathological and Clinical Features of Lipocalin-Type Prostaglandin D2 Synthase as a Multifunctional Lipocalin
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Implications of a Clinically Ignored Site of Acanthosis Nigricans: The Knuckles
- A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome
- Management of polycystic ovarian syndrome through Homoeopathy: A Case Report
- Compendium of polycystic ovarian syndrome and its relevance in glycation and diabetes
- Management OF Patients with Polycystic Ovary Syndrom
- Polycystic Ovary Syndrome: A Comprehensive Review of Its Clinical Presentation, Comorbidities, Long-Term Complications and Management
- PATHOGENETIC FEATURES OF THE INFLUENCE OF A PAST CORONAVIRUS INFECTION IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
- Polikistik Over Sendromu ve Obezite: FTO ve MC4R Gen Polimorfizmlerinin Rolü
- CUTANEOUS MANIFESTATIONS OF POLYCYSTIC OVARIAN DISEASE
- Metabolic Aspects of Polycystic Ovary Syndrome
- Metabolic Aspects of Polycystic Ovary Syndrome
- Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome
- Insulin Resistance and Polycystic Ovary Syndrome
- Decreased lipin 1β expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome
- Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review
- POLYCYSTIC OVARY SYNDROME: PATHOGENESIS, TREATMENT AND SECONDARY ASSOCIATED DISEASES
- Machine learning-based steroid metabolome analysis reveals three distinct subtypes of polycystic ovary syndrome and implicates 11-oxygenated androgens as major drivers of metabolic risk
- Polycystic Ovarian Disease (PCOD): A comprehensive review of pathophysiology, clinical manifestations, psychological impact, and therapeutic approaches
- Polycystic ovary syndrome and infertility: an update
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity
- PCOS in Adolescents—Ongoing Riddles in Diagnosis and Treatment
- Update on polycystic ovary syndrome